| 000 | 01112 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513002152.0 | ||
| 264 | 0 | _c19830407 | |
| 008 | 198304s 0 0 eng d | ||
| 022 | _a0098-1532 | ||
| 024 | 7 |
_a10.1002/mpo.2950100715 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSlevin, M L | |
| 245 | 0 | 0 |
_aThe pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy. _h[electronic resource] |
| 260 |
_bMedical and pediatric oncology _c1982 |
||
| 300 |
_a157-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 700 | 1 | _aPiall, E M | |
| 700 | 1 | _aAherne, G W | |
| 700 | 1 | _aJohnston, A | |
| 700 | 1 | _aLister, T A | |
| 773 | 0 |
_tMedical and pediatric oncology _gvol. 10 Suppl 1 _gp. 157-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mpo.2950100715 _zAvailable from publisher's website |
| 999 |
_c6961997 _d6961997 |
||